Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.
So what: The cash or stock deal — Angle shareholders can opt for $3.85 in cash or 0.4734 of a Bellatrix common share — values Angle at around $3.97 per share, representing a premium of 24% to its Tuesday closing price. Bellatrix expects the acquisition to be accretive on production, cash flow, reserves, and net asset value per share, but judging by its own stock’s 5% plunge, Mr. Market isn’t too thrilled with the price management is paying to do it.
Now what: The deal is expected to close in mid-December 2013. “Angle’s shareholders will benefit from this business combination with Bellatrix,” said Angle CEO Gregg Fischbuch in a statement. “This complementary transaction creates one of the largest Cardium producers and landholders in Alberta and provides Angle shareholders an attractive price.” So while Angle shares are likely all popped out at this point, Bellatrix’s newly bolstered asset base might be worth looking into.
Looking for more small cap ideas? Click here now to check out the Motley Fool Canada’s small cap stock for 2013 – and beyond! FREE!
The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead.
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool does not own shares in any of the companies mentioned.